Hence, we treated WT and SU-R ccRCC cells with PCD-1, and the results suggested that inhibition of CYP1B1 suppressed the protein expression of HIF2α in a time- and dose-dependent manner (Figure S7B). This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.